BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9069535)

  • 1. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
    Péchinot A; Neuwirth C; Bryskier A; Duez JM; Kazmierczak A
    J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefodizime.
    Knothe H; Shah PM
    Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-vitro activity of cefodizime: a review.
    Soussy CJ; Chanal M; Kitzis MD
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefodizime (HR-221).
    Ahonkhai VI; Cherubin CE; Shulman MA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S; Aswapokee N; Aswapokee P
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Antimicrob Agents Chemother; 1981 Dec; 20(6):760-8. PubMed ID: 6275785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial activity of cefodizime against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K
    Jpn J Antibiot; 1993 Oct; 46(10):860-76. PubMed ID: 8254888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O; Roche G; Bouanchaud DH
    Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of cephalosporins by beta-lactamases of gram-negative rods.
    Bauernfeind A; Petermüller C; Jungwirth R
    Infection; 1983; 11 Suppl 1():S39-43. PubMed ID: 6339417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
    Stobberingh EE; Houben AW
    Chemotherapy; 1988; 34(6):490-6. PubMed ID: 3072153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic action of cefodizime with other antimicrobial agents on clinically isolated microorganisms. II. Synergistic action with sisomicin].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1992 Jan; 45(1):1-11. PubMed ID: 1495193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.